The 6 startups are one step closer to winning access into NOME’s elite Mentoring Program and receiving the NOME Prize of 50 000 DKK. With 90+ high-quality applications submitted to the NOME Startup Competition 2020, saying that the competition was tough is an understatement.

On November 18, the finalists will pitch to the jury of NOME mentors, who will select the winner of the NOME prize and that will also be granted access to the Mentoring Program, strategic advice from world-class industry mentors, and a global network.

“I think the six selected cases are very interesting and definitely represent those who have the highest potential and the best traction”, says Peter Birk, Accelerace.

Under normal circumstances, the Startup Competition is scheduled as a major part of the NOME Annual Meeting. However, due to the development of COVID-19 in Denmark, the Startup Competition 2020 will instead take place online.

Meet the 6 finalists

The 6 finalists are from Denmark, Finland, Sweden, and Norway, and represent an innovative set of initiatives that have realized significant results in therapeutics and medical devices.

StatuManu (Denmark): provides a non-invasive solution for measuring and monitoring of intracranial pressure (ICP) by tracking changes in ICP, with the mission of saving the brain and saving lives 

Sartar Therapeutics (Finland): provides new treatment options for sarcomas that fail to respond to current therapies by offering a controlled-release formulation of anagrelide, SAR001

StemSight (Finland): provides an off-the-shelf cell therapy product for the treatment of limbal stem cell deficiency, a severe for of corneal blindness, based on highly potent limbal epithelial cells obtained from human pluripotent stem cells

Mode Sensors (Norway): develops the first medical-grade sensor-patch for real-time hydration monitoring, Re:Balans, to help caregivers prevent fluid imbalance, which contributes to reducing mortality, medical complications, and hospitalizations

Developeration (Sweden): offers a new operation device, PexyEazy®, which enables surgery in only 10 minutes and without the need for anesthesia when removing hemorrhoids

Inorbit Therapeutics (Sweden): discovered a new generation small molecule Farnesoid X Receptor (FXR) agonist, IOT022, which mitigates the risk for Drug-Induced Liver Injury (DILI) and pruritus


About NOME:

The Nordic Mentor Network for Entrepreneurship (NOME) is an elite Mentoring Program for Nordic startups within therapeutics, medical devices, diagnostics, digital health, and industrial biotech. Since 2016, the ambition has been to propel selected startups into internationally renowned commercial successes by matching them with highly-skilled volunteer professionals.

NOME is funded by the Novo Nordisk Foundation and driven by the partner organizations Accelerace (Denmark), Oslo Cancer Cluster Incubator and Aleap (Norway), Karolinska Institutet Innovations AB and Medicon Village (Sweden) as well as Vertical Accelerator and Turku Science Park Ltd (Finland).